Monica Niger

2.6k total citations · 1 hit paper
63 papers, 982 citations indexed

About

Monica Niger is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Monica Niger has authored 63 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 30 papers in Surgery and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Monica Niger's work include Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Colorectal Cancer Treatments and Studies (12 papers). Monica Niger is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Pancreatic and Hepatic Oncology Research (13 papers) and Colorectal Cancer Treatments and Studies (12 papers). Monica Niger collaborates with scholars based in Italy, United States and Germany. Monica Niger's co-authors include Filippo de Braud, Filippo Pietrantonio, Maria Di Bartolomeo, Marcello Deraco, Dario Baratti, Shigeki Kusamura, Sara Pusceddu, Federico Nichetti, Marcello Guagliò and Francesca Corti and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Monica Niger

56 papers receiving 971 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer

2024 47 citations Federico Nichetti, Sara Pusceddu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Niger Italy	16	469	370	323	287	260	63	982
Hideto Fujita Japan	21	584 1.2×	402 1.1×	508 1.6×	417 1.5×	184 0.7×	95	1.3k
Alessia Mennitto Italy	19	549 1.2×	212 0.6×	479 1.5×	271 0.9×	225 0.9×	59	1.0k
Shaobo Mo China	21	506 1.1×	213 0.6×	256 0.8×	203 0.7×	198 0.8×	57	883
Caj Haglund Finland	15	427 0.9×	483 1.3×	240 0.7×	335 1.2×	147 0.6×	34	1.1k
Genichi Nishimura Japan	20	399 0.9×	659 1.8×	550 1.7×	322 1.1×	153 0.6×	62	1.5k
Yuichi Arimoto Japan	13	376 0.8×	429 1.2×	313 1.0×	330 1.1×	165 0.6×	35	1.0k
Pengfei Kong China	19	678 1.4×	276 0.7×	381 1.2×	174 0.6×	237 0.9×	41	1.1k
Wenzhuo He China	19	878 1.9×	296 0.8×	279 0.9×	241 0.8×	325 1.3×	84	1.3k
Hisatoshi Nakagawara Japan	21	517 1.1×	485 1.3×	341 1.1×	211 0.7×	122 0.5×	68	1.1k
Xiangbing Deng China	17	524 1.1×	337 0.9×	185 0.6×	367 1.3×	197 0.8×	81	1.0k

Countries citing papers authored by Monica Niger

Since Specialization

Citations

This map shows the geographic impact of Monica Niger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Niger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Niger more than expected).

Fields of papers citing papers by Monica Niger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Niger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Niger. The network helps show where Monica Niger may publish in the future.

Co-authorship network of co-authors of Monica Niger

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Niger. A scholar is included among the top collaborators of Monica Niger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Niger. Monica Niger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pietrantonio, Filippo, Federica Morano, Monica Niger, et al.. (2024). The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial. Clinical Cancer Research. 31(4). 649–658. 2 indexed citations

Maspero, Marianna, Carlo Sposito, Marco Bongini, et al.. (2024). Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study. Transplant International. 37. 13641–13641. 2 indexed citations

Rimassa, Lorenza, Giovanni Brandi, Monica Niger, Nicola Normanno, & Davide Melisi. (2023). Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement. Critical Reviews in Oncology/Hematology. 192. 104146–104146. 5 indexed citations

Barretta, Francesco, Francesca Corti, Sara Lonardi, et al.. (2023). Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(1). e005493–e005493. 13 indexed citations

Nichetti, Federico, Sara Lonardi, Filippo Pietrantonio, et al.. (2023). Comparative Genomic Analysis and Clinical Outcomes of BRAF -mutated Advanced Biliary Tract Cancers. Clinical Cancer Research. 29(23). 4853–4862. 8 indexed citations

Raimondi, Alessandra, Federico Nichetti, Arndt Stahler, et al.. (2023). Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials. European Journal of Cancer. 190. 112945–112945. 7 indexed citations

Pietrantonio, Filippo, Federica Morano, Monica Niger, et al.. (2023). 641P Phase I/II study of the EP4 antagonist CR6086 combined with the anti-PD-1 balstilimab in mismatch-repair-proficient and microsatellite stable (pMMR/MSS) chemorefractory metastatic colorectal cancer (mCRC). Annals of Oncology. 34. S452–S453. 2 indexed citations

Silvestri, Marco, Trung Nghia Vu, Federico Nichetti, et al.. (2023). Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma. Cancer Medicine. 12(8). 10156–10168. 7 indexed citations

Rizzato, Mario Domenico, Monica Niger, Lorenzo Fornaro, et al.. (2023). P-343 The impact of genomic alterations on response rate and survival outcomes in advanced BTC patients who receive cisplatin/gemcitabine plus durvalumab in clinical practice. Annals of Oncology. 34. S135–S135. 2 indexed citations

10.

Pilla, Lorenzo, Kathrin Heinrich, Volker Kunzmann, et al.. (2023). Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.. Journal of Clinical Oncology. 41(16_suppl). 4148–4148.

11.

Pietrantonio, Filippo, Paolo Manca, Sara E. Bellomo, et al.. (2022). HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial. Clinical Cancer Research. 29(3). 571–580. 15 indexed citations

12.

Pusceddu, Sara, Claudio Vernieri, Natalie Prinzi, et al.. (2020). The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence. Therapeutic Advances in Gastroenterology. 13. 3974116135–3974116135. 9 indexed citations

13.

Pusceddu, Sara, Roberta Rossi, Martina Torchio, et al.. (2020). Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors. Journal of Clinical Medicine. 9(8). 2468–2468. 12 indexed citations

14.

Corti, Francesca, Federico Nichetti, Alessandra Raimondi, et al.. (2018). Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treatment Reviews. 72. 45–55. 89 indexed citations

15.

Bartolomeo, Maria Di, Monica Niger, Maria Maddalena Laterza, et al.. (2016). Safety and efficacy profile of ramucirumab alone or combined with paclitaxel in metastatic gastric cancer (MGC): A real-life overview of compassionate-use named patients (pts) (RAMoss study). Annals of Oncology. 27. vi216–vi216.

16.

Bartolomeo, Maria Di, Alessandro Pellegrinelli, Roberto Iacovelli, et al.. (2015). Association with programmed death ligand-1 (PDL-1) expression and Helicobacter Pylori infection in patients with non-diffuse type gastric carcinoma. Annals of Oncology. 26. vi93–vi93. 2 indexed citations

17.

Baratti, Dario, Shigeki Kusamura, Filippo Pietrantonio, et al.. (2015). Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer at high risk for the development of peritoneal metastases. A matched case-control study. Annals of Oncology. 26. vi42–vi42. 1 indexed citations

18.

Celio, Luigi, et al.. (2015). Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy. PubMed. 10. 75–75. 21 indexed citations

19.

Agustoni, Francesco, et al.. (2014). Folfirinox in Pancreatic Cancer: the National Cancer Institute of Milan Single Experience. Annals of Oncology. 25. ii50–ii50. 1 indexed citations

20.

Procopio, Giuseppe, et al.. (2011). Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors. Neurological Sciences. 32(S2). 217–219. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact